Aug. 17 at 2:12 AM
$CMPX
Three firms moved on August 7 — Canaccord reaffirmed Buy, Piper Sandler kept Buy, and most significantly Leerink raised their price target from
$4 to
$7. That analyst activity is what’s been fueling the move from
$1.86 on August 4 to
$2.35 today — a 26% recovery in one week with no new clinical or regulatory news.
